Drug Trial Radar · NCT00326898
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
Last checked: Nov 19, 2026Latest source record: Jun 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,943
Actual
Start
Apr 24, 2006
Primary completion
Aug 27, 2015
Study completion Sep 1, 2021
Sponsor
- Lead sponsor
- National Cancer Institute (NCI)NIH
- Sponsor type
- NIH
- Collaborators
- Cancer and Leukemia Group B; NCIC Clinical Trials Group; SWOG Cancer Research Network
- First posted
- May 17, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This randomized phase III trial studies sunitinib malate to see how well it works compared to sorafenib tosylate or placebo in treating patients with kidney cancer that has been removed by surgery. Sunitinib malate and sorafenib tosylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. Giving sunitinib malate or sorafenib tosylate after surgery may kill any tumor cells that remain after surgery. It is not yet known whether sunitinib malate is more effective than sorafenib tosylate or placebo in treating kidney cancer.
Conditions
- Clear Cell Renal Cell Carcinoma
- Stage I Renal Cell Cancer AJCC v6 and v7
- Stage II Renal Cell Cancer AJCC v7
- Stage III Renal Cell Cancer AJCC v7
Interventions
Laboratory Biomarker AnalysisOther
Correlative studies
PlaceboOther
Given PO
Quality-of-Life AssessmentOther
Ancillary studies
Sorafenib TosylateDrug
Given PO
Sunitinib MalateDrug
Given PO
Primary outcomes
What the sponsor says the trial is designed to measure.
- Disease-free Survival (DFS)Time frame: Assessed every 3 months if patient is < 2 years from study entry; every 6 months if patient is 2 - 5 years from study entry; then annually if patient is 5 - 10 years from study entry
Locations
987 sites in 3 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama
Clearview Cancer Institute
Huntsville, Alabama
Mobile Infirmary Medical Center
Mobile, Alabama
Providence Hospital
Mobile, Alabama
University of South Alabama Mitchell Cancer Institute
Mobile, Alabama
Providence Alaska Medical Center
Anchorage, Alaska
Fairbanks Memorial Hospital
Fairbanks, Alaska
Banner Thunderbird Medical Center
Glendale, Arizona
Banner-University Medical Center Phoenix
Phoenix, Arizona
Western Regional CCOP
Phoenix, Arizona
Mayo Clinic in Arizona
Scottsdale, Arizona
Banner University Medical Center - Tucson
Tucson, Arizona
Sparks Regional Medical Center
Fort Smith, Arkansas
CHI Saint Vincent Cancer Center Hot Springs
Hot Springs, Arkansas
University of Arkansas for Medical Sciences
Little Rock, Arkansas
Highlands Oncology Group-Rogers
Rogers, Arkansas
Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California
Providence Saint Joseph Medical Center/Disney Family Cancer Center
Burbank, California
Mills-Peninsula Medical Center
Burlingame, California
East Bay Radiation Oncology Center
Castro Valley, California
Eden Hospital Medical Center
Castro Valley, California
Valley Medical Oncology Consultants-Castro Valley
Castro Valley, California
John Muir Medical Center-Concord Campus
Concord, California
City of Hope Comprehensive Cancer Center
Duarte, California
Bay Area Breast Surgeons Inc
Emeryville, California
Kaiser Permanente-Fremont
Fremont, California
Valley Medical Oncology Consultants-Fremont
Fremont, California
Washington Hospital
Fremont, California
Saint Jude Medical Center
Fullerton, California
Glendale Memorial Hospital and Health Center
Glendale, California
Marin Cancer Care Inc
Greenbrae, California
Marin General Hospital
Greenbrae, California
Saint Rose Hospital
Hayward, California
Loma Linda University Medical Center
Loma Linda, California
Veterans Affairs Loma Linda Healthcare System
Loma Linda, California
USC / Norris Comprehensive Cancer Center
Los Angeles, California
Contra Costa Regional Medical Center
Martinez, California
Fremont - Rideout Cancer Center
Marysville, California
Memorial Medical Center
Modesto, California
Community Hospital of Monterey Peninsula
Monterey, California
Showing 40 of 987 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.